当前位置: 首页 > 期刊 > 《中国当代医药》 > 202027
编号:13806742
单用二甲双胍血糖控制不佳时联合西格列汀治疗的临床效果(5)
http://www.100md.com 2020年9月25日 《中国当代医药》 202027
     [16]Buse JB,Freeman JL,Edelman SV,et al.Serum 1,5-anhydroglucitol (GlycoMark):a short-term glycaemic marker[J].Diabetes Technol Ther,2003,5(3):355-363.

    [17]Wang Y,Zhang YL,Wang YP.A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China[J].Diabetes Metab Res Rev,2012,28(4):357-362.

    [18]Matsuyama T,Katayama Y,Fujita S,et al.Recent progress in evaluation of glycemic control by glicated and 1,5-AG[J].Rinsho Byori,1995,43(5):445-448.

    [19]邱文升.1,5-脫水山梨醇的基础与临床[J]中国糖尿病杂志,1997,(2):41-43.

    [20]DamS JK,Torgun W,Arne Y,et al.Stromal cell-derived factor-1alpha in unstable angina:potential antiinflammatory and matrix-stabilizing effects[J].Circulation,2002,106(1):36-42.

    [21]Takahashi M.Role of the SDF-1/CXCR4 system in myocardial infarction[J].Circ J,2010,74(3):418-423.

    [22]Kucia M,Jankowski K,Reca R,et al.CXCR4-SDF-1 Signalling,Locomotion,Chemotaxis and Adhesion[J].J Mol Histol,2004,35(3):233-245.

    (收稿日期:2020-03-16), 百拇医药(曾菊丽 罗贤 贺五风)
上一页1 2 3 4 5